Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
ProPhase Labs in discussions for strategic initiative to realize significant underlying value in the Company. Voting for Curren...
ProPhase Labs (NASDAQ:PRPH) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.1...
Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for E...
